Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

@article{Engelhardt2005AntiinflammatoryAA,
  title={Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance},
  author={G. Engelhardt and D. Homma and K. Schlegel and R. Utzmann and C. Schnitzler},
  journal={Inflammation Research},
  year={2005},
  volume={44},
  pages={423-433}
}
The anti-inflammatory, analgesic and antipyretic properties of the new non-steroidal anti-inflammatory agent, meloxicam, were investigated in a variety of animal models and compared with the properties of piroxicam, diclofenac, indomethacin and several other NSAIDs.With respect to the total effect of a single oral dose, the anti-exudative effect of meloxicam on carrageenaninduced oedema in the rat exceeded that of all the NSAIDs included in the comparison. Additionally, meloxicam showed the… Expand
Modulation of the pharmacological properties of meloxicam by octreotide in rats
TLDR
Both meloxicam and octreotide and their combination significantly decreased the malondialdehyde content in the arthritic rats indicating their antioxidant effects. Expand
Acute studies on safety index of nonsteroidal anti-inflammatory drugs in rats
TLDR
The safety index of preferential COX-2 inhibitor (nimesulide, meloxicam) was investigated using carrageenan-induced paw oedema and acute ulcerogenic model in rats, compared with the classical NSAIDs (naproxen, indomethacin). Expand
A comparison between the effects of meloxicam and other nsaids on the production of oxyradicals by human polymorphonuclear leucocytes
Some non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the production or actions of oxygen radicals generated by polymorphonuclear leucocytes (PMNs); this mechanism may contribute towards theirExpand
Comparative Evaluation of the Analgesic Effect of Brand and Generics of Meloxicam tablets Available in markets
Meloxicam is one of non-steroidal anti-inflammatory drugs (NSAIDs) used for relief of pain and inflammation. It works by inhibition of cyclooxygenase enzymes which are responsible for ProstaglandinsExpand
Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety
TLDR
The pharmacokinetics of meloxicam enables once daily application, which increases compliance compared with some shorter acting NSAIDs; however, long-term clinical data clearly demonstrating safety and efficacy advantages are lacking. Expand
Role of Indomethacin in Acute Pain and Inflammation Management: A Review of the Literature
TLDR
This review provides an historic overview of indomethacin and its efficacy compared with other commonly used analgesics, and discusses new indometHacin drug products. Expand
Analgesic, Anti-Inflammatory and Ulcerogenic Studies of Meloxicam Solid Dispersion in Rodents
Meloxicam is a non steroidal anti-inflammatory drug, used in the treatment of rheumatoid arthritis and oestoarthritis. It is practically insoluble in water leading to poor dissolution, variations inExpand
Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk.
TLDR
Results indicate that solid dispersion possess better analgesic and anti-inflammatory properties with less ulcerogenic potential as compared to pure meloxicam. Expand
Meloxicam: A potent inhibitor of adjuvant arthritis in the Lewis rat
TLDR
Findings indicate that the action of meloxicam and piroxicam differs from that of diclofenac and tenidap in adjuvant arthritis in the Lewis rat. Expand
Synthesis and evaluation of anti-inflammatory and analgesic activity of some substituted thiazolyl and thaizolidinonyl tetrahydronapthalene derivatives
Abstract A new series of 1,2,3,4-tetrahydronaphthalen-6-yl-thiazole and thiazolidinone derivatives were synthesized. Twenty four of the newly synthesized compounds were evaluated for theirExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
Meloxicam: A toxicology overview
TLDR
Toxicological testing of meloxicam in animals suggests that acute oral overdosage is unlikely to cause severe toxicity in man, and the drug in animal tests exhibits potential antiarthritic action and has a wider spectrum of anti-inflammatory activity than currently available NSAIDs. Expand
A biochemical basis for the gastrointestinal toxicity of non-steroid antirheumatoid drugs.
  • B. Whittle, J. Vane
  • Chemistry, Medicine
  • Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement
  • 1984
TLDR
The development of nonsteroid anti-rheumatic drugs which have minimal action on prostaglandin production by the gastro-intestinal tract and exhibit reduced gastrointestinal toxicity appears to be a feasible proposition. Expand
Biological activity of the main metabolites of meloxicam.
TLDR
It can be concluded that the metabolites of Meloxicam do not change renal blood flow and therefore have no capability for nephrotoxicity, in accordance with the observations in the rat kidney during subacute and chronic toxicity studies, where no neph rotoxic effects could be detected after therapeutic doses. Expand
Effect of a new anti-inflammatory compound, CGP 28237, on arachidonate metabolism in rat gastrointestinal tissue
TLDR
CGP 28237 (5-methlysulfonylamino-6-phenoxy1-indanone), a new NSAID, is equipotent with indomethacin in the rat adjuvant arthritis test and has an outstanding gastrointestinal tolerability in this species up to the highest dose tested. Expand
Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats.
TLDR
Adjuvant arthritis of rats is established as an experimental model for testing antiartliritic drugs and it is suggested that this model would be more useful for drug evaluation with improved techniques for measuring joint swelling and tenderness. Expand
Analgesic antipyretic drugs as antagonists of bradykinin.
TLDR
The antagonism between analgesic antipyretic drugs and bradykinin was examined quantitatively, using the bronchoconstrictor response of guinea-pigs in vivo and a method of measuring the potency of this anti-bradykinIn action was developed. Expand
An analysis of piroxicam in rodent models of arthritis
TLDR
Piroxicam inhibited rat adjuvant disease and its associated manifestations, which include erosion of bone and cartilage, soft tissue swelling and disease-induced weight loss, in several rodent models of arthritis. Expand
The effect of locally injected anti-inflammatory drugs on the synthesis of collagen and non-collagen protein of carrageenin granuloma in rats.
TLDR
Sodium salicylate significantly reduced the synthesis of collagen in the granulomatous tissue without affecting non-collagen protein synthesis, and among the non-steroids tested, indomethacin and phenylbutazone failed to show any significant changes in the synthesis. Expand
Distribution of [14C]meloxicam in joints of rats with adjuvant arthritis.
Using the new non-steroidal anti-inflammatory agent meloxicam (Mel), comparative investigations on pharmacokinetics and metabolism show good agreement between results in man and in the rat. ToExpand
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
TLDR
Whether selective inhibition of prostaglandin production, assayed as PGE2-like activity, in the inflammatory exudate can be achieved in vivo is investigated and it is reported here that it can. Expand
...
1
2
3
4
5
...